In a report released today, Gregory Renza from RBCCapital maintained a Buy rating on Perspective Therapeutics (CATX – Research Report). The company’s shares closed yesterday at $6.96. Don't Miss ...
On Friday, CoStar Group Inc (CSGP) stock saw a decline, ending the day at $71.25 which represents a decrease of $-3.79 or -5.05% from the prior close of $75.04. The stock opened at $74.96 and touched ...
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...